https://www.selleckchem.com/pr....oducts/Mubritinib-TA
46%, p 0.001). Hospital stay was shorter in the LMH group than in the OMH group (5 vs. 7days, p = 0.01). Mortality at 90days was comparable between the two groups. There were no significant differences between the two groups in terms of overall survival (OS) and disease-free survival (DFS) at 1, 3, and 5years. LMH for HCC is associated with appropriate short-term outcomes in patients aged ≥ 70years as compared to OMH. LMH is safe and feasible in elderly patients with HCC. LMH for HCC is associated with appropriate short-
Like
Comment
Share
